Abstracts

864 – Liraglutide for Obesity in HIV (LIROH): A Single-Arm, Open-Label Clinical Trial in South Africa

Background Obesity is a common complication of treated HIV, especially among Black Women. Yet, perceptions of optimal body weight among people living with HIV (PLWH) may influence interest in anti-obesity medical therapies. We conducted a pilot clinical trial to assess the acceptability, tolerability, and preliminary efficacy of liraglutide for obesity management in virologically suppressed PLWH…

844 – PLHIV Exhibit a COVID-19 Independent Increase of Cardiovascular Mortality in Brazil, 2019-2023

Background Cardiovascular disease (CVD) is a leading cause of morbidity and mortality among PLHIV. The COVID-19 pandemic exacerbated existing health disparities, particularly affecting vulnerable populations. This study aims to investigate the impact of the COVID-19 pandemic on death rates due to CVD in Brazil. Methods All data were sourced from Brazilian Mortality Information System (SIM)…

932 – Longitudinal Changes in Arterial Stiffness and Inflammation From Pre- to Post-COVID-19 Infection

Background We have previously shown in cross-sectional studies that COVID-19 infection was associated with arterial stiffness and increased oxidized LDL (oxLDL).  In this study, we assess changes in these cardiovascular parameters after COVID infection in a group of individuals who have documented pre-COVID assessments.  Having pre-COVID assessments has been a limitation of current studies.  Methods…

942 – Immune Profile of Children With Post-COVID-19 Cardiac Contractility Alterations: A Prospective Study

Background Myocardial injuries have been observed after COVID-19 in previously healthy children, regardless of COVID-19 severity. Immune dysregulation may play a role in post-COVID cardiac alterations but remains unexplored in children. This study evaluated the immune response in children with or without asymptomatic cardiac contractility alterations after mild SARS-CoV-2 infection. Methods A prospective, observational study…

891 – Re-Examining InSTI Effects on Weight Gain Among Treatment-Naive People With HIV in North America

Background Prior analyses highlighted the association between starting INSTI-based antiretroviral therapy (ART) and weight gain among treatment-naïve people with HIV (PWH) in the North American AIDS Cohort Collaboration on Research & Design (NA-ACCORD). However, it is unclear whether observed relative weight gain after INSTI initiation reflected weight-suppressive effects of older NNRTIs or confounding due to…

889 – Multimorbidity and Quality of Life Among Older People Living With HIV in Urban Tanzania

Background Approximately one-third of Tanzanians living with HIV are aged ≥50. Aging persons living with HIV (PLWH) are at a higher risk of multi-morbidities compared to older persons without HIV. Multi-morbidities can have a significant negative impact on quality of life (QOL). This study assessed the distribution of geriatric and medical comorbidities and their association with…

939 – Distinct Proinflammatory/Proangiogenetic Signatures Distinguish Children With Long COVID

Background Recent proteomic studies have documented that Long Covid in adults is characterized by a pro-inflammatory signature with thromboinflammation. However, if similar events happen also in children with Long Covid has never been investigated. Methods We performed proteomics analyses of blood plasma from pediatric patients younger than 19 years of age Long Covid and sex-…

830 – BMI Is a Poor Surrogate for Excess Visceral Adiposity and Cardiovascular Risk in Persons With HIV

Background Recent studies demonstrate substantial weight gain among people with HIV (PWH) starting modern antiretroviral (ART) regimens, as well as a high prevalence of obesity among those on long-term treatment. As a result, routine body mass index (BMI) measurements have been proposed to assess cardiovascular (CV) and other comorbid illness risk. However, prior studies show…